Page last updated: 2024-08-23

etoposide and ly2510924

etoposide has been researched along with ly2510924 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flynt, A; Hamid, O; McCleod, M; Polzer, J; Roberson, S; Salgia, R; Spigel, DR; Stille, JR; Weaver, RW	1

Trials

1 trial(s) available for etoposide and ly2510924

Article	Year
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2017, Volume: 105 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Peptides, Cyclic; Proportional Hazards Models; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome	2017

Article

Year

A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.

Lung cancer (Amsterdam, Netherlands), 2017, Volume: 105

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Peptides, Cyclic; Proportional Hazards Models; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome

2017